7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

SciSparc Ltd
(NASDAQ:SPRC) 

SPRC stock logo

SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.

Founded: 2004
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS

Share this website to your friends
SciSparc Days Payable Outstanding ttm (DPO)
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0194.16388.32582.48776.64970.81,164.961,359.11
SciSparc Days Receivable Outstanding ttm (DSO)
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 013.4826.9640.4453.9267.480.8894.36
SciSparc Days Inventory Outstanding ttm (DIO)
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0108.17216.34324.52432.69540.86649.03757.2
SciSparc Op Cashflow Per Share ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -31.64-27.12-22.6-18.08-13.56-9.04-4.52-0
SciSparc Free Cashflow Per Share ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -48.83-41.86-34.88-27.91-20.93-13.95-6.980
SciSparc Cash Per Share ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.052.13.154.25.256.37.35
SciSparc P/S ratio ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.262.513.775.026.287.538.79
SciSparc (GAAP) P/E ratio ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -14.05-11.48-8.92-6.35-3.78-1.221.353.92
SciSparc P/B ratio ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.811.612.423.234.034.845.65
No extra charts and metrics for this ticker.